Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.6100
+0.0252 (4.31%)
At close: May 22, 2026, 4:00 PM EDT
0.6338
+0.0238 (3.90%)
After-hours: May 22, 2026, 7:07 PM EDT
Vivos Therapeutics Employees
Vivos Therapeutics had 268 employees as of December 31, 2025. The number of employees increased by 159 or 145.87% compared to the previous year.
Employees
268
Change
159
Growth
145.87%
Revenue / Employee
$73,015
Profits / Employee
-$93,239
Market Cap
8.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 268 | 159 | 145.87% | 268 | 0 |
| Sep 30, 2025 | 262 | 153 | 140.37% | 262 | 0 |
| Jun 30, 2025 | 113 | - | - | 113 | 0 |
| Mar 31, 2025 | 113 | -10 | -8.13% | 113 | 0 |
| Dec 31, 2024 | 109 | -14 | -11.38% | 109 | 0 |
| Dec 31, 2023 | 123 | -40 | -24.54% | 114 | 9 |
| Mar 31, 2023 | 159 | -6 | -3.64% | 159 | 0 |
| Dec 31, 2022 | 163 | -4 | -2.40% | 154 | 9 |
| Sep 30, 2022 | 170 | 23 | 15.65% | 170 | 0 |
| Jun 30, 2022 | 180 | 47 | 35.34% | 180 | 0 |
| Mar 31, 2022 | 165 | 55 | 50.00% | 165 | 0 |
| Dec 31, 2021 | 167 | 69 | 70.41% | 158 | 9 |
| Sep 30, 2021 | 147 | 50 | 51.55% | 147 | 0 |
| Jun 30, 2021 | 133 | 49 | 58.33% | 133 | 0 |
| Mar 31, 2021 | 110 | 26 | 30.95% | 110 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 401 |
| Picard Medical | 75 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
VVOS News
- 4 days ago - Vivos Therapeutics reports Q1 EPS (52c), consensus (45c) - TheFly
- 4 days ago - Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update - GlobeNewsWire
- 4 days ago - Vivos Therapeutics Quarterly report: Q1 2026 - Filings
- 4 days ago - Vivos Therapeutics Earnings release: Q1 2026 - Filings
- 15 days ago - Analysts see 200%+ upside in these 3 high-risk stocks: here's why? - Invezz
- 25 days ago - Vivos Therapeutics Registration statement: Registration filing - Filings
- 5 weeks ago - Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright - TheFly
- 5 weeks ago - Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global - TheFly